Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Telemonitoring During Phase 2-3 Cardiac Rehabilitation (TeleRehabII)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by Jessa Hospital.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Paul Dendale, Jessa Hospital Identifier:
First received: December 1, 2010
Last updated: October 1, 2012
Last verified: September 2012

In this study, 80 coronary artery disease patients with successful coronary revascularisation (by CABG or PCI) will be included. Patients are excluded in case of: congestive heart failure, ICD or pacemaker, any disability limiting exercise participation.

These patients are attending phase 2-3 cardiac rehabilitation, and have completed 6 weeks of rehabilitation. Next, subjects are randomly assigned to a control group (continue rehabilitation for another 18 weeks) or an intervention group (continue rehabilitation for another 18 weeks, but being confronted regularly with their physical activity (by wearing physical activity monitors)).

Outcome parameters: physical activity, exercise capacity, blood glucose, insulin level and lipid profile, body weight and waist circumference, cardiovascular morbidity and mortality.

Hypothesis: telemonitoring of physical activity will not increase physical activity, nor improve cardiovascular disease risk factors, in CAD patients attending phase 2-3 cardiac rehabilitation.

Condition Intervention Phase
Ischemic Heart Disease
Device: physical activity monitors
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: Impact of Telemonitoring Intervention on Physical Activity, CVD Risk Factors, During Phase 2-3 Cardiac Rehabilitation

Resource links provided by NLM:

Further study details as provided by Jessa Hospital:

Primary Outcome Measures:
  • Physical activity [ Time Frame: every week ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • exercise capacity [ Time Frame: every 6 weeks ] [ Designated as safety issue: No ]
  • blood lipid profile, glucose and insulin level [ Time Frame: every 6 weeks ] [ Designated as safety issue: No ]
  • mortality and morbidity [ Time Frame: continuously ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 80
Study Start Date: January 2011
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: intervention
stimulation of physical activity by messages sent through e mail or SMS
Device: physical activity monitors
physical activity monitors
Placebo Comparator: control
no stimulation of physical activity
Device: physical activity monitors
physical activity monitors


Ages Eligible for Study:   40 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria: CAD patients following phase 2-3 rehabilitation -

Exclusion Criteria: CHF, pacemaker, ICD, any disability limiting exercise participation


  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01252030

Jessa Hospital
Hasselt, Belgium, 3500
Sponsors and Collaborators
Jessa Hospital
Principal Investigator: Paul A Dendale, MD, PhD University of Hasselt, Hasselt, Belgium
  More Information

No publications provided

Responsible Party: Paul Dendale, dr, Jessa Hospital Identifier: NCT01252030     History of Changes
Other Study ID Numbers: Telemonitoring 2
Study First Received: December 1, 2010
Last Updated: October 1, 2012
Health Authority: Belgium: Institutional Review Board

Keywords provided by Jessa Hospital:
CAD, physical activity, rehabilitation, prevention

Additional relevant MeSH terms:
Coronary Artery Disease
Heart Diseases
Myocardial Ischemia
Arterial Occlusive Diseases
Cardiovascular Diseases
Coronary Disease
Vascular Diseases processed this record on November 24, 2014